Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13752)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 7, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Damião AOMC, Azevedo MFC, Carlos AS, Wada MY, Silva TVM, Feitosa FC. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review. World J Gastroenterol 2019; 25(9): 1142-1157 [PMID: 30863001 DOI: 10.3748/wjg.v25.i9.1142] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i9/1142.htm |
| Number | Citing Articles |
| 1 |
Stein Bergan, Mercè Brunet, Dennis A. Hesselink, Kamisha L. Johnson-Davis, Paweł K. Kunicki, Florian Lemaitre, Pierre Marquet, Mariadelfina Molinaro, Ofelia Noceti, Smita Pattanaik, Tomasz Pawinski, Christoph Seger, Maria Shipkova, Jesse J. Swen, Teun van Gelder, Raman Venkataramanan, Eberhard Wieland, Jean-Baptiste Woillard, Tom C. Zwart, Markus J. Barten, Klemens Budde, Maja-Theresa Dieterlen, Laure Elens, Vincent Haufroid, Satohiro Masuda, Olga Millan, Tomoyuki Mizuno, Dirk J. A. R. Moes, Michael Oellerich, Nicolas Picard, Linda Salzmann, Burkhard Tönshoff, Ron H. N. van Schaik, Nils Tore Vethe, Alexander A. Vinks, Pierre Wallemacq, Anders Åsberg, Loralie J. Langman. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic Drug Monitoring 2021; 43(2): 150 doi: 10.1097/FTD.0000000000000871
|
| 2 |
Yoshiyuki Kimura, Kimye Baba. Xanthoangelol Isolated from Angelica keiskei Roots Prevents Dextran Sulfate Sodium-Treated Colitis in Mice. The Natural Products Journal 2020; 10(5): 655 doi: 10.2174/2210315510999200515100203
|
| 3 |
Juan Decara, Patricia Rivera, Antonio Jesús López-Gambero, Antonia Serrano, Francisco Javier Pavón, Elena Baixeras, Fernando Rodríguez de Fonseca, Juan Suárez. Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00730
|
| 4 |
Pengyu Lei, Haiyang Yu, Jiahui Ma, Jiao Du, Yimeng Fang, Qinsi Yang, Kun Zhang, Li Luo, Libo Jin, Wei Wu, Da Sun. Cell membrane nanomaterials composed of phospholipids and glycoproteins for drug delivery in inflammatory bowel disease: A review. International Journal of Biological Macromolecules 2023; 249: 126000 doi: 10.1016/j.ijbiomac.2023.126000
|
| 5 |
Miaohua Liu, Fuchun Liu, Yuanle Pan, Yi Xiong, Xin Zeng, LinXin Zheng, Haimei Zhao, Yanzhen Li, Duanyong Liu. Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR/NF-κB pathway. International Immunopharmacology 2023; 115: 109612 doi: 10.1016/j.intimp.2022.109612
|
| 6 |
Nuno-Valério Silva, Diogo Carregosa, Catarina Gonçalves, Otília V. Vieira, Cláudia Nunes dos Santos, António Jacinto, Carolina Lage Crespo. A Dietary Cholesterol-Based Intestinal Inflammation Assay for Improving Drug-Discovery on Inflammatory Bowel Diseases. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.674749
|
| 7 |
Lisann Müller, Thomas Kuhn, Marcus Koch, Gregor Fuhrmann. Stimulation of Probiotic Bacteria Induces Release of Membrane Vesicles with Augmented Anti-inflammatory Activity. ACS Applied Bio Materials 2021; 4(5): 3739 doi: 10.1021/acsabm.0c01136
|
| 8 |
Yuki Ozato, Tomoaki Hara, Sikun Meng, Hiromichi Sato, Shotaro Tatekawa, Mamoru Uemura, Takeshi Yabumoto, Shizuka Uchida, Kazuhiko Ogawa, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. RNA methylation in inflammatory bowel disease. Cancer Science 2024; 115(3): 723 doi: 10.1111/cas.16048
|
| 9 |
Niranjan G. Kotla, Rajbir Singh, Becca V. Baby, Swetha Rasala, Jawad Rasool, Sean O. Hynes, Darrell Martin, Laurence J. Egan, Praveen K. Vemula, Venkatakrishna R. Jala, Yury Rochev, Abhay Pandit. Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease. Biomaterials 2022; 281: 121364 doi: 10.1016/j.biomaterials.2022.121364
|
| 10 |
Haiyan Zhou, Yuri Ikeuchi-Takahashi, Yoshiyuki Hattori, Hiraku Onishi. Nanogels of a Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Release Behavior, Gastrointestinal Distribution, and Systemic Absorption. International Journal of Molecular Sciences 2020; 21(7): 2376 doi: 10.3390/ijms21072376
|
| 11 |
Bihui Liu, Lei Yang, Ya Wu, Xin Zhao. Protective effect of Limosilactobacillus fermentum HFY06 on dextran sulfate sodium-induced colitis in mice. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.935792
|
| 12 |
Yoshiyuki Kimura. Preventive Effects of Mallotus japonicus Cortex Extracts on Dextran Sulfate Sodium-Induced Ulcerative Colitis in C57 BL/6J Mice. The Natural Products Journal 2020; 10(2): 177 doi: 10.2174/2210315509666191106112622
|
| 13 |
Anton J. Kroesen. Early Surgery in Inflammatory Bowel Diseases Is a Better Option than Prolonged Conservative Treatment. Visceral Medicine 2019; 35(6): 355 doi: 10.1159/000504150
|
| 14 |
Natália Sousa Freitas Queiroz, Takayuki Yamamoto, Paulo Gustavo Kotze. Optimal strategies to prevent recrudescent Crohn's disease after resection. Seminars in Colon and Rectal Surgery 2020; 31(2): 100746 doi: 10.1016/j.scrs.2020.100746
|
| 15 |
Maryam Alkhatry, Ahmad Al-Rifai, Vito Annese, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul Nathwani, Mazen S Taha, Jimmy K Limdi. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World Journal of Gastroenterology 2020; 26(43): 6710-6769 doi: 10.3748/wjg.v26.i43.6710
|
| 16 |
Yishan Zhou, Bingling Zhong, Xiangjing Min, Ying Hou, Ligen Lin, Qin Wu, Jingshan Shi, Xiuping Chen. Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF‐κB p65. Phytotherapy Research 2021; 35(10): 5861 doi: 10.1002/ptr.7246
|
| 17 |
Linshan Duan, Shuyu Cheng, Long Li, Yanling Liu, Dan Wang, Guoyan Liu. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.684486
|
| 18 |
Han Wang, Yaxuan Sun, Xuan Ma, Tianyu Yang, Feng Wang. The Lactobacillus plantarum P-8 Probiotic Microcapsule Prevents DSS-Induced Colitis through Improving Intestinal Integrity and Reducing Colonic Inflammation in Mice. Nutrients 2024; 16(7): 1055 doi: 10.3390/nu16071055
|
| 19 |
Yating Niu, Jun Zhang, Dianhua Shi, Weibiao Zang, Jianguo Niu. Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review. Molecules 2023; 28(13): 5210 doi: 10.3390/molecules28135210
|
| 20 |
Yangyan Xiu, Kaizhen Wang, Jingfang Chen, Zhiqiang Zhuo, Yanghui Xiu. Liposomal N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis. RSC Advances 2020; 10(56): 34197 doi: 10.1039/D0RA05264G
|
| 21 |
Tianyu Zhu, Qingkai Xue, Yiyun Liu, Yongliang Xu, Chunrong Xiong, Jin Lu, Haitao Yang, Quan Zhang, Yuzheng Huang. Analysis of Intestinal Microflora and Metabolites From Mice With DSS-Induced IBD Treated With Schistosoma Soluble Egg Antigen. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.777218
|
| 22 |
Mariem Abaach, Ian Morilla. Learning models for colorectal cancer signature reconstruction and classification in patients with chronic inflammatory bowel disease. Artificial Intelligence in Cancer 2022; 3(2): 27-41 doi: 10.35713/aic.v3.i2.27
|
| 23 |
Guosheng Lin, Minyao Li, Nan Xu, Xiaoli Wu, Jingjing Liu, Yulin Wu, Qian Zhang, Jian Cai, Changjun Gao, Ziren Su, Mohammad Hassan Baig. Anti-Inflammatory Effects of Heritiera littoralis Fruits on Dextran Sulfate Sodium- (DSS-) Induced Ulcerative Colitis in Mice by Regulating Gut Microbiota and Suppressing NF-κB Pathway. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8893621
|
| 24 |
Jiapei Cai, Jiuxi Liu, Peng Fan, Xue Dong, Kunpeng Zhu, Xiaobo Liu, Naisheng Zhang, Yongguo Cao. Dioscin prevents DSS-induced colitis in mice with enhancing intestinal barrier function and reducing colon inflammation. International Immunopharmacology 2021; 99: 108015 doi: 10.1016/j.intimp.2021.108015
|
| 25 |
François Blachier. Metabolism of Alimentary Compounds by the Intestinal Microbiota and Health. 2023; : 27 doi: 10.1007/978-3-031-26322-4_2
|
| 26 |
B. Bokemeyer, M. Ghiani, A. Fuchs, B. Deiters, F. Hardtstock, A. Brandes, J. Knop, H. D. Orzechowski, T. Wilke. Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting. International Journal of Colorectal Disease 2020; 35(8): 1587 doi: 10.1007/s00384-020-03588-w
|
| 27 |
Jiahui Peng, Chunhai Li, Zhe Wang, Songsen Sui, Chuanzhuang Guo, Ruiting Zhao, Haoran Liu, Ting Wang, Zhenshang Xu, Rotimi Aluko. Development of a Functional Food Based on the Fermentation Broth of Jiegeng for the Treatment of Inflammatory Bowel Disease. Journal of Food Biochemistry 2023; 2023: 1 doi: 10.1155/2023/8815971
|
| 28 |
Aderson Omar Mourão Cintra Damião, Natália Sousa Freitas Queiroz. Medical Therapy in Chronic Refractory Ulcerative Colitis: When Enough Is Enough. Clinics in Colon and Rectal Surgery 2022; 35(01): 032 doi: 10.1055/s-0041-1740036
|
| 29 |
Fares E.M. Ali, Mohamed M. Elfiky, Walaa A. Fadda, Howaida S. Ali, Amany Refaat Mahmoud, Zuhair M. Mohammedsaleh, Tarek Hamdy Abd-Elhamid. Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: Novel mechanistic insight. Life Sciences 2021; 276: 119433 doi: 10.1016/j.lfs.2021.119433
|
| 30 |
Yuge Zhao, Ruiqing He, Jie Zang, Weimin Yin, Runping Su, Wei Xiong, Weihua Xu, Jiaxin Zhang, Yiqiong Liu, Tianbin Ren, Yongzhuo Huang, Yongyong Li. Pathologically catalyzed physical coating restores the intestinal barrier for inflammatory bowel disease therapy. Journal of Nanobiotechnology 2023; 21(1) doi: 10.1186/s12951-023-02227-0
|
| 31 |
Yoshiyuki Kimura. Effects of kampo medicine keishikashakuyakuto on large intestine disease in mice. Traditional & Kampo Medicine 2019; 6(3): 165 doi: 10.1002/tkm2.1232
|
| 32 |
Chenqi Chang, Heng Liu, Xiaotong Li, Dandan Song, Yue Liu, Chang Lu, Yu Zhen, Ying Chen, Jinguo Xu, Weidong Li, Xiaobin Jia, Zhipeng Chen, Rui Chen. Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model. International Journal of Nanomedicine 2024; : 1205 doi: 10.2147/IJN.S442761
|
| 33 |
Rosario García-Vicuña, Noemí Garrido, Susana Gómez, Beatriz Joven, Rubén Queiro, Julio Ramírez, Francisco Rebollo, Estíbaliz Loza, Agustí Sellas. Management of particular clinical situations in psoriatic arthritis: an expert’s recommendation document based on systematic literature review and extended Delphi process. Rheumatology International 2021; 41(9): 1549 doi: 10.1007/s00296-021-04877-5
|
| 34 |
Jing-Jing Wang, Yi-Hong Fan. Advances in research of tacrolimus for treatment of inflammatory bowel disease. World Chinese Journal of Digestology 2019; 27(13): 842 doi: 10.11569/wcjd.v27.i13.842
|
| 35 |
Yifan Wang, Zhexing Shou, Heng Fan, Meng Xu, Qianyun Chen, Qing Tang, Xingxing Liu, Hui Wu, Man Zhang, Ting Yu, Shuangjiao Deng, Yujin Liu. Protective effects of oxymatrine against DSS-induced acute intestinal inflammation in mice via blocking the RhoA/ROCK signaling pathway. Bioscience Reports 2019; 39(7) doi: 10.1042/BSR20182297
|
| 36 |
Han Li, Bo Pang, Bin Nie, Shifang Qu, Kuanxin Zhang, Jinxiu Xu, Ming Yang, Jie Liu, Shasha Li. Dioscin promotes autophagy by regulating the AMPK-mTOR pathway in ulcerative colitis. Immunopharmacology and Immunotoxicology 2022; 44(2): 238 doi: 10.1080/08923973.2022.2037632
|
| 37 |
Xinxin Xia, Hai Lin, Feijun Luo, Xiuxiu Wu, Lingfeng Zhu, Shuilian Chen, Han Luo, Fan Ye, Xia Peng, Yan Zhang, Guliang Yang, Qinlu Lin. Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage via Targeting the Gut Microbiota Accompanied by the TLR4/NF-κB/NLRP3 Cascade Response In Vivo. Journal of Agricultural and Food Chemistry 2022; 70(50): 15747 doi: 10.1021/acs.jafc.2c04354
|
| 38 |
Cintia M. S. Cereda, Giovana R. Tofoli. Biotechnology Applied to Inflammatory Diseases. Interdisciplinary Biotechnological Advances 2023; : 287 doi: 10.1007/978-981-19-8342-9_13
|
| 39 |
Michal Weitman, Corina Bejar, Michal Melamed, Tehilla Weill, Inessa Yanovsky, Shani Zeeli, Abraham Nudelman, Marta Weinstock. Comparison of the tissue distribution and metabolism of AN1284, a potent anti-inflammatory agent, after subcutaneous and oral administration in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(10): 2077 doi: 10.1007/s00210-021-02125-y
|
| 40 |
Yichen Li, Faisal Raza, Yuhao Liu, Yiqi Wei, Ruonan Rong, Mengyuan Zheng, Weien Yuan, Jing Su, Mingfeng Qiu, Y. Li, F. Raza, Y. Liu, Y. Wei, R. Rong, M. Zheng, W. Yuan, J. Su, M. Qiu. Clinical progress and advanced research of red blood cells based drug delivery system. Biomaterials 2021; 279: 121202 doi: 10.1016/j.biomaterials.2021.121202
|
| 41 |
Pierre-Olivier Harmand, Jérôme Solassol. Thiopurine Drugs in the Treatment of Ulcerative Colitis: Identification of a Novel Deleterious Mutation in TPMT. Genes 2020; 11(10): 1212 doi: 10.3390/genes11101212
|
| 42 |
Lingling Qv, Sunbing Mao, Yongjun Li, Jia Zhang, Lanjuan Li. Roles of Gut Bacteriophages in the Pathogenesis and Treatment of Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.755650
|
| 43 |
Shi Liu, Hui Shen, Jiyan Li, Ying Gong, Haidong Bao, Jingyuan Zhang, Lanqing Hu, Zhengpeng Wang, Jian Gong. Loganin inhibits macrophage M1 polarization and modulates sirt1/NF-κB signaling pathway to attenuate ulcerative colitis. Bioengineered 2020; 11(1): 628 doi: 10.1080/21655979.2020.1774992
|
| 44 |
Panu Wetwittayakhlang, Talat Bessissow, Peter L. Lakatos. Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials. Expert Opinion on Emerging Drugs 2024; 29(1): 19 doi: 10.1080/14728214.2024.2303116
|
| 45 |
Yoshiyuki Kimura, Masahiko Taniguchi, Takuo Okuda. Acertannin Prevented Dextran Sulfate Sodium-induced Colitis by Inhibiting the Colonic Expression of IL-23 and TNF-α in C57BL/6J Mice. Planta Medica 2023; 89(07): 746 doi: 10.1055/a-2037-2995
|
| 46 |
Ha-Yeon Song, Woo Sik Kim, Jin-Man Kim, Dong-Ho Bak, Jeong Moo Han, Seung-Taik Lim, Eui-Baek Byun. A hydroxyethyl derivative of chrysin exhibits anti-inflammatory activity in dendritic cells and protective effects against dextran sodium salt-induced colitis in mice. International Immunopharmacology 2019; 77: 105958 doi: 10.1016/j.intimp.2019.105958
|
| 47 |
Yifan Wang, Xueyun Duan, Xingxing Liu, Yujin Liu, Heng Fan, Meng Xu, Qianyun Chen, Qing Tang. Rho kinase Blockade Ameliorates DSS-Induced Ulcerative Colitis in Mice Through Dual Inhibition of the NF-κB and IL-6/STAT3 Pathways. Inflammation 2020; 43(3): 857 doi: 10.1007/s10753-019-01171-2
|
| 48 |
Moto Kitayama, Yuko Akazawa, Daisuke Yoshikawa, Shuntaro Higashi, Tomohito Morisaki, Hidetoshi Oda, Maho Ikeda, Yujiro Nakashima, Maiko Tabuchi, Keiichi Hashiguchi, Kayoko Matsushima, Naoyuki Yamaguchi, Hisayoshi Kondo, Kazuhiko Nakao, Fuminao Takeshima. Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-68828-z
|
| 49 |
Takashi Kitani, Sushma C. Maddipatla, Ramya Madupuri, Christopher Greco, Jonathan Hartmann, James N. Baraniuk, Sona Vasudevan. In Search of Newer Targets for Inflammatory Bowel Disease: A Systems and a Network Medicine Approach. Network and Systems Medicine 2021; 4(1): 74 doi: 10.1089/nsm.2020.0012
|
| 50 |
Ligia Yukie Sassaki, Sender J Miszputen, Roberto Luiz Kaiser Junior, Wilson R Catapani, Mauro Bafutto, António S Scotton, Cyrla Zaltman, Julio Pinheiro Baima, Hagata S Ramos, Mikaell Alexandre Gouvea Faria, Carolina D Gonçalves, Isabella Miranda Guimaraes, Cristina Flores, Heda M B S Amarante, Rodrigo Bremer Nones, José Miguel Luz Parente, Murilo Moura Lima, Júlio Maria Chebli, Maria de Lourdes Abreu Ferrari, Julia F Campos, Maria G P Sanna, Odery Ramos, Rogério Serafim Parra, Jose J R da Rocha, Omar Feres, Marley R Feitosa, Rosana Fusaro Caratin, Juliana Tosta Senra, Genoile Oliveira Santana. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil. World Journal of Gastroenterology 2021; 27(23): 3396-3412 doi: 10.3748/wjg.v27.i23.3396
|
| 51 |
Jun Yu, Hao Chen, Jiangmei Xu, Peng Zhou. Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases. Molecular and Cellular Biochemistry 2022; 477(4): 1075 doi: 10.1007/s11010-022-04354-y
|
| 52 |
Elena González-Lozano, Jorge García-García, Julio Gálvez, Laura Hidalgo-García, Alba Rodríguez-Nogales, María Elena Rodríguez-Cabezas, Manuel Sánchez. Novel Horizons in Postbiotics: Lactobacillaceae Extracellular Vesicles and Their Applications in Health and Disease. Nutrients 2022; 14(24): 5296 doi: 10.3390/nu14245296
|
| 53 |
Laura Conti, Elisabetta Bolli, Antonino Di Lorenzo, Valentina Franceschi, Francesca Macchi, Federica Riccardo, Roberto Ruiu, Luca Russo, Elena Quaglino, Gaetano Donofrio, Federica Cavallo. Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer. Cancer Immunology Research 2020; 8(8): 1039 doi: 10.1158/2326-6066.CIR-20-0082
|
| 54 |
Oana-Irina Nistor, Christina Godfrey, Amanda Ross-White, Rosemary Wilson. Systematic Review and Meta-analysis on the Incidence, Prevalence and Determinants of Discomfort in Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology 2022; 5(2): 96 doi: 10.1093/jcag/gwab043
|